Gary B. Gordon

Insider Reports History

Location
C/O Ayala Pharmaceuticals, Inc., Oppenheimer 4, Rehovot, Israel
Signature
/s/ Mary Szela, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gary B. Gordon:

Stock Role Class Num Shares Value Price $ Report Date Ownership
TriSalus Life Sciences, Inc. Director Director Stock Option (right to buy) 56.3K Jun 12, 2025 Direct
Old Ayala, Inc Chief Medical Officer Common Stock 0 Jan 19, 2023 Direct
Old Ayala, Inc Chief Medical Officer Stock Option (right to buy) 0 Jan 19, 2023 Direct

Insider Reports Filed by Gary B. Gordon

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TLSI TriSalus Life Sciences, Inc. Jun 12, 2025 1 $0 4 Jun 27, 2025 Director
TLSI TriSalus Life Sciences, Inc. Jan 29, 2025 2 $0 4 Jan 31, 2025 Director
TLSI TriSalus Life Sciences, Inc. Jan 29, 2025 0 $0 3 Jan 31, 2025 Director
AYLA Old Ayala, Inc Jan 19, 2023 4 $0 4 Jan 23, 2023 Chief Medical Officer
AYLA Ayala Pharmaceuticals, Inc. May 16, 2022 1 $0 4 May 16, 2022 Chief Medical Officer
AYLA Ayala Pharmaceuticals, Inc. Jan 3, 2022 1 $0 4 Jan 5, 2022 Chief Medical Officer